Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
2.640
-0.305 (-10.36%)
At close: Apr 3, 2025, 4:00 PM
2.754
+0.114 (4.32%)
After-hours: Apr 3, 2025, 5:24 PM EDT

Lexeo Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-98.33-66.39-59.28-50.62-5.15
Depreciation & Amortization
21.841.150.01-
Loss (Gain) From Sale of Investments
-0.02----
Stock-Based Compensation
12.473.041.780.39-
Other Operating Activities
-0.53--1.87
Change in Accounts Payable
2.38-0.18-0.433.020.04
Change in Unearned Revenue
---0.05-0.090.01
Change in Income Taxes
---0.020.490.04
Change in Other Net Operating Assets
0.351.662.292.630.06
Operating Cash Flow
-81.15-59.5-54.56-44.18-3.13
Capital Expenditures
-0.48-0.12-0.67-0.19-
Sale (Purchase) of Intangibles
--0.05-0.23--
Investment in Securities
-93.6----
Investing Cash Flow
-94.08-0.17-0.9-0.19-
Short-Term Debt Issued
-4---
Long-Term Debt Issued
----2.6
Total Debt Issued
-4--2.6
Long-Term Debt Repaid
-0.41-0.43-0.16--
Net Debt Issued (Repaid)
-0.413.58-0.16-2.6
Issuance of Common Stock
95.49111.590.330.17-
Repurchase of Common Stock
-0.02----
Other Financing Activities
-6.29-11.37--0.37-0.22
Financing Cash Flow
88.78103.790.19150.8632.38
Net Cash Flow
-86.4544.13-55.27106.4929.25
Free Cash Flow
-81.63-59.61-55.23-44.37-3.13
Free Cash Flow Margin
---8445.26%-2677.73%-604.35%
Free Cash Flow Per Share
-2.57-11.13-33.88-28.58-2.17
Cash Interest Paid
0.130.18---
Cash Income Tax Paid
--0.08--
Levered Free Cash Flow
-48.43-35.22-33.67-25.48-
Unlevered Free Cash Flow
-48.34-35.1-33.62-25.48-
Change in Net Working Capital
-3.77-3-2.18-5.96-
Updated Mar 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q